- Home
- ACRS vs SHIP Comparison
ACRS vs SHIP Comparison
Compare ACRS & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRS
- SHIP
- Stock Information
- Founded
- ACRS 2012
- SHIP 2008
- Country
- ACRS United States
- SHIP Greece
- Employees
- ACRS N/A
- SHIP N/A
- Industry
- ACRS Biotechnology: Pharmaceutical Preparations
- SHIP Marine Transportation
- Sector
- ACRS Health Care
- SHIP Consumer Discretionary
- Exchange
- ACRS Nasdaq
- SHIP Nasdaq
- Market Cap
- ACRS 165.7M
- SHIP 153.8M
- IPO Year
- ACRS 2015
- SHIP 2007
- Fundamental
- Price
- ACRS $1.80
- SHIP $7.81
- Analyst Decision
- ACRS Strong Buy
- SHIP Strong Buy
- Analyst Count
- ACRS 9
- SHIP 1
- Target Price
- ACRS $9.25
- SHIP $11.00
- AVG Volume (30 Days)
- ACRS 1.4M
- SHIP 103.0K
- Earning Date
- ACRS 08-07-2025
- SHIP 08-05-2025
- Dividend Yield
- ACRS N/A
- SHIP 10.16%
- EPS Growth
- ACRS N/A
- SHIP N/A
- EPS
- ACRS N/A
- SHIP 0.73
- Revenue
- ACRS $16,789,000.00
- SHIP $147,718,000.00
- Revenue This Year
- ACRS N/A
- SHIP N/A
- Revenue Next Year
- ACRS $8.11
- SHIP $20.86
- P/E Ratio
- ACRS N/A
- SHIP $10.72
- Revenue Growth
- ACRS N/A
- SHIP 1.66
- 52 Week Low
- ACRS $1.05
- SHIP $4.78
- 52 Week High
- ACRS $5.17
- SHIP $12.65
- Technical
- Relative Strength Index (RSI)
- ACRS 62.45
- SHIP 70.55
- Support Level
- ACRS $1.75
- SHIP $7.22
- Resistance Level
- ACRS $1.92
- SHIP $7.46
- Average True Range (ATR)
- ACRS 0.09
- SHIP 0.24
- MACD
- ACRS 0.01
- SHIP 0.02
- Stochastic Oscillator
- ACRS 70.00
- SHIP 98.77
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Geniuship, Premiership, Squireship, And Friendship.